The impact of dementia on antidiabetic drug use in Medicare beneficiaries with diabetes: Findings post-Medicare part D

Z. Kevin Lu, Minghui Li, Karen McGee, Cynthia M. Phillips, Jing Yuan, S. Scott Sutton

Research output: Contribution to journalArticle

Abstract

Aim: The objectives of the study were to measure the utilization rates of antidiabetic drugs in diabetic patients with dementia and to assess the impact of dementia on antidiabetic drug use. Materials & methods: This study was a pooled cross-sectional study of the Medicare Current Beneficiaries Survey from 2006 to 2010. Results & conclusion: Lower utilizations of biguanides, DPP-4 inhibitors and thiazolidinediones were observed in dementia patients. The likelihood of using antidiabetic drugs was about 30% (odds ratio: 0.69; 95% CI: 0.56-0.84) lower in dementia patients and 40% (odds ratio: 0.61; 95% CI: 0.44-0.84) lower in patients with Alzheimer's disease. Healthcare providers should be aware of underuse of antidiabetic drugs in patients with dementia.

Original languageEnglish (US)
Pages (from-to)383-392
Number of pages10
JournalJournal of Comparative Effectiveness Research
Volume5
Issue number4
DOIs
StatePublished - Jul 1 2016

Fingerprint

Medicare Part D
Medicare
Hypoglycemic Agents
Dementia
Odds Ratio
Biguanides
Thiazolidinediones
Health Personnel
Alzheimer Disease
Cross-Sectional Studies

All Science Journal Classification (ASJC) codes

  • Health Policy

Cite this

The impact of dementia on antidiabetic drug use in Medicare beneficiaries with diabetes : Findings post-Medicare part D. / Lu, Z. Kevin; Li, Minghui; McGee, Karen; Phillips, Cynthia M.; Yuan, Jing; Sutton, S. Scott.

In: Journal of Comparative Effectiveness Research, Vol. 5, No. 4, 01.07.2016, p. 383-392.

Research output: Contribution to journalArticle

Lu, Z. Kevin ; Li, Minghui ; McGee, Karen ; Phillips, Cynthia M. ; Yuan, Jing ; Sutton, S. Scott. / The impact of dementia on antidiabetic drug use in Medicare beneficiaries with diabetes : Findings post-Medicare part D. In: Journal of Comparative Effectiveness Research. 2016 ; Vol. 5, No. 4. pp. 383-392.
@article{223b62534e83465ca62be1276a505f3e,
title = "The impact of dementia on antidiabetic drug use in Medicare beneficiaries with diabetes: Findings post-Medicare part D",
abstract = "Aim: The objectives of the study were to measure the utilization rates of antidiabetic drugs in diabetic patients with dementia and to assess the impact of dementia on antidiabetic drug use. Materials & methods: This study was a pooled cross-sectional study of the Medicare Current Beneficiaries Survey from 2006 to 2010. Results & conclusion: Lower utilizations of biguanides, DPP-4 inhibitors and thiazolidinediones were observed in dementia patients. The likelihood of using antidiabetic drugs was about 30{\%} (odds ratio: 0.69; 95{\%} CI: 0.56-0.84) lower in dementia patients and 40{\%} (odds ratio: 0.61; 95{\%} CI: 0.44-0.84) lower in patients with Alzheimer's disease. Healthcare providers should be aware of underuse of antidiabetic drugs in patients with dementia.",
author = "Lu, {Z. Kevin} and Minghui Li and Karen McGee and Phillips, {Cynthia M.} and Jing Yuan and Sutton, {S. Scott}",
year = "2016",
month = "7",
day = "1",
doi = "10.2217/cer-2015-0006",
language = "English (US)",
volume = "5",
pages = "383--392",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6305",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - The impact of dementia on antidiabetic drug use in Medicare beneficiaries with diabetes

T2 - Findings post-Medicare part D

AU - Lu, Z. Kevin

AU - Li, Minghui

AU - McGee, Karen

AU - Phillips, Cynthia M.

AU - Yuan, Jing

AU - Sutton, S. Scott

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Aim: The objectives of the study were to measure the utilization rates of antidiabetic drugs in diabetic patients with dementia and to assess the impact of dementia on antidiabetic drug use. Materials & methods: This study was a pooled cross-sectional study of the Medicare Current Beneficiaries Survey from 2006 to 2010. Results & conclusion: Lower utilizations of biguanides, DPP-4 inhibitors and thiazolidinediones were observed in dementia patients. The likelihood of using antidiabetic drugs was about 30% (odds ratio: 0.69; 95% CI: 0.56-0.84) lower in dementia patients and 40% (odds ratio: 0.61; 95% CI: 0.44-0.84) lower in patients with Alzheimer's disease. Healthcare providers should be aware of underuse of antidiabetic drugs in patients with dementia.

AB - Aim: The objectives of the study were to measure the utilization rates of antidiabetic drugs in diabetic patients with dementia and to assess the impact of dementia on antidiabetic drug use. Materials & methods: This study was a pooled cross-sectional study of the Medicare Current Beneficiaries Survey from 2006 to 2010. Results & conclusion: Lower utilizations of biguanides, DPP-4 inhibitors and thiazolidinediones were observed in dementia patients. The likelihood of using antidiabetic drugs was about 30% (odds ratio: 0.69; 95% CI: 0.56-0.84) lower in dementia patients and 40% (odds ratio: 0.61; 95% CI: 0.44-0.84) lower in patients with Alzheimer's disease. Healthcare providers should be aware of underuse of antidiabetic drugs in patients with dementia.

UR - http://www.scopus.com/inward/record.url?scp=84978066080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978066080&partnerID=8YFLogxK

U2 - 10.2217/cer-2015-0006

DO - 10.2217/cer-2015-0006

M3 - Article

C2 - 27302883

AN - SCOPUS:84978066080

VL - 5

SP - 383

EP - 392

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

SN - 2042-6305

IS - 4

ER -